Immix Biopharma, Inc.
Immix Biopharma, Inc.（IMMX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
immx · 股价预测 · 4 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 4 位华尔街分析师
Buy
4 位分析师
共识
评级分布
12 个月目标价
High
$20.00
Consensus
$17.00
+116.0% upside
Low
$14.00
Median: $17 · Last Close: $7.87
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$17.00
116.0% upside
High Target
$20
154.1%
Low Target
$14
77.9%
Current Price
$7.87
as of today
Based on analyst price targets, the IMMX stock price prediction for the next 12 months ranges from $14 to $20. The consensus IMMX price forecast of $17.00 implies 116.0% upside from the current price of $7.87.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $7.48 | ↓ 5.00% |
1-day model range: $7.42–$7.54. Peak: $7.54 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $8 | +1.1% |
| 2028 | $8 | +1.7% |
| 2029 | $8 | +2.0% |
| 2030 | $8 | +2.2% |
| 2031 | — | +2.3% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · IMMX · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-30 | Mizuho | Maintains | Outperform→Outperform |
| 2026-03-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-27 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-12-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-06-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Immix Biopharma, Inc. (IMMX) stock. Of the recent 16 rating actions, 0 were upgrades and 0 were downgrades. 4 analysts currently cover IMMX.
分析师推荐趋势
IMMX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$12M
↓ 94.1% YoY
Revenue Next Year
$56M
↑ 364.7% YoY
EPS This Year
$-0.70
EPS Next Year
$-0.65
↓ 7.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast IMMX EPS of $-0.70 for the current fiscal year, based on estimates from 4 analysts. The IMMX revenue forecast is $12M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
IMMX 股价预测由两类独立数据源支撑：来自 4 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。IMMX 的共识目标价为 $17.00（+116.0% 上行空间），分析师共识为 Buy。
IMMX 的短期预测（明日）为 $7.48（-5.00%）。 IMMX 对 2027 年的股价预测均值为 $8。 IMMX 对 2030 年的预测区间为 $7–$9。
Immix Biopharma, Inc. 在 NASDAQ 上市，代码 IMMX。IMMX 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
IMMX 预测 · 8 个问题根据 4 位华尔街分析师，IMMX 的 12 个月平均目标价为 $17.00，最高 $20.00、最低 $14.00。若有图表，中位目标价可在上方查看。相对当前价 $7.87，隐含约 +116.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.